We both reported similar expression trends for plasma EV levels of transferrin (reduced expression in nodal OTSCC relative to non-cancer controls), serum amyloid A-2 protein (reduced expression in nodal OTSCC relative to non-nodal disease), and partially similar trends for platelet factor 4 variant 1 (increased expression in non-nodal OTSCC and reduced expression in nodal OTSCC relative to non-cancer controls). The gene discussed is TF; the disease is cancer.